Site Reference ID/Investigator# 95379 — Cedarhurst, New York

Site Reference ID/Investigator# 95379 is a clinical research site located in Cedarhurst, New York, United States 11516.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 95379 has participated in 1 clinical trials.

Therapeutic areas: Schizophrenia.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cedarhurst

Browse all research sites in New York · View every site in Cedarhurst

• Neurobehavioral Research
• Research Site
• Five Towns Neuroscience Research
• Clinical Site
• Neurocrine Clinical Site
• Investigational Site
• Cedarhurst
• Pfizer Investigational Site
• Teva Investigational Site 14772
• Otsuka Investigational Site
• Novartis Investigative Site
• Neumora Investigator Site

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 95379?

Site Reference ID/Investigator# 95379 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 95379 conducted?

Site Reference ID/Investigator# 95379 has 1 clinical trials on record. Their work covers Schizophrenia.

Is Site Reference ID/Investigator# 95379 accredited by Crixeo Clinical Trials?

Site Reference ID/Investigator# 95379 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 95379?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.